Article

Hepatitis C Drug Breakthrough Highlights Specialty Pharmacy Week in Review

Author(s):

Davy James, Managing Editor

Top news of the week on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/hepatitis-c-drug-breakthrough-warning-highlights-s" target="_blank">View the story "Hepatitis C Drug Breakthrough Highlights Specialty Pharmacy Week in Review" on Storify</a>]

Related Videos
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards
Related Content
Wildfire, Pharmacy, Preparedness | Image Credit: JAH | stock.adobe.com
January 10th 2025

As Wildfires Spread Across California, Pharmacists' Role in the Crisis Proves Essential

Ashley Gallagher, Editor
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Editor
Primary biliary cholangitis written on post-it note -- Image credit: syahrir | stock.adobe.com
January 10th 2025

FDA Grants Orphan Drug Designation to CNP-104 for Primary Biliary Cholangitis

Gillian McGovern, Associate Editor
Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations
January 25th 2024

Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations

FDA headquarters at White Oak Campus in Silver Spring, Maryland, USA - January 13, 2020. The United States Food and Drug Administration (FDA) is a federal agency
January 9th 2025

FDA Grants Breakthrough Therapy Designation to Tividenofusp Alfa for Treatment of Hunter Syndrome

Luke Halpern, Assistant Editor
Microscopic image of an adrenal cortical adenoma, a benign tumor of the adrenal gland, which may produce hormones cortisol or aldosterone and lead to Cushing's syndrome or primary hyperaldosteronism.
January 6th 2025

Relacorilant NDA Submitted to FDA for Treatment of Endogenous Hypercortisolism

Luke Halpern, Assistant Editor